Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human telomerase reverse transcriptase (hTERT) promoter G-quadruplex is a non-canonical DNA secondary structure located within the GC-rich core promoter region of the hTERT gene (PMID: 27103548). This structure is formed by guanine-rich sequences that stack into G-tetrads, stabilized by Hoogsteen hydrogen bonding and monovalent cations. Biologically, these G-quadruplexes act as transcriptional silencers; when stabilized, they prevent the binding of essential transcription factors and the assembly of the transcription machinery, thereby downregulating TERT expression (PMID: 30103543). In approximately 90% of human cancers, TERT is overexpressed to maintain telomere length, providing the cellular immortality necessary for tumor progression. Mutations in the hTERT promoter, such as C228T and C250T, are frequently observed in various malignancies and can influence G-quadruplex stability or create new binding sites for transcription factors like GABP (PMID: 32663434). Small-molecule ligands designed to target and stabilize the hTERT promoter G-quadruplex are being developed as potential anti-cancer therapies to silence telomerase activity and induce senescence in cancer cells. However, achieving high selectivity for the hTERT G-quadruplex over the thousands of other G4 structures in the human genome remains a significant therapeutic challenge (PMID: 32824111).
Stabilization of the G-quadruplex structure within the hTERT promoter region to sterically hinder the binding of transcription factors (such as Sp1 and c-Myc) and RNA polymerase II, thereby suppressing TERT gene transcription and inhibiting telomerase activity (PMID: 31100571, 32824111).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human telomerase reverse transcriptase promoter G-quadruplex (hTERT promoter G4).